Production of MV-NIS product under GMP conditions and conducting clinical studies in two phases
Phase 1 clinical study:
Status: Preparing contract manufacturing
Required duration: 1 year
Phase 2 clinical study:
Required duration: 3 years
Biotechnological drug development to treat children with congenital defects of a metabolic enzyme
The beginning of the project in April 2022
Scientific and commercial studies have been carried out